Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$30,472,980
-$1,908,549 QoQ
Shares Held
471,499
-2.0% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 98.07592380895824.ToString("F0")%
Shared 0.ToString("F0")%
None 1.9240761910417625.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE GROUP LLC holds $57,437,743 across 5 Biotechnology names. HALO ranks #1 (53.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
471,499 | $30,472,980 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
445,215 | $11,023,523 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
51,168 | $9,673,310 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
642,535 | $5,789,240 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,072 | $478,690 |
All Filings in HALO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,472,980 | 471,499 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $32,381,529 | 481,152 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $35,110,424 | 478,735 | Shares | Defined | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||